BOLD
Boundless Bio, Inc.
-0.03 (-1.06%)2.79USD64.3K成交股數63.5M市值–本益比(近四季)–股價營收比–營收年增(近四季)–下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | – | – | – | – | – | – | – | – | – | – |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 14.0M | 9.7M | 9.8M | 10.7M | 12.2M | 12.1M | 14.1M | 14.7M | 13.1M | 10.4M | 11.6M | 11.1M |
| 銷售管理費用 | 10.4M | 4.7M | 4.2M | 4.5M | 4.8M | 5.2M | 4.6M | 4.7M | 3.8M | 3.4M | 3.3M | 2.9M |
| 營業利益 | −24.4M+43% | −14.5M-17% | −14.0M-25% | −15.1M-22% | −17.1M+1% | −17.3M+26% | −18.7M+25% | −19.4M+39% | −16.9M | −13.8M | −15.0M | −14.0M |
| 營業利益率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稅後淨利 | −23.7M+51% | −13.6M-14% | −12.9M-22% | −13.9M-18% | −15.7M+2% | −15.8M+30% | −16.5M+25% | −17.0M+37% | −15.4M | −12.1M | −13.2M | −12.4M |
| 淨利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稀釋 EPS | -1.06+51% | -0.60-15% | -0.57-23% | -0.62-19% | -0.70-94% | -0.71-93% | -0.74-93% | -0.77-93% | -12.27 | -9.75 | -10.71 | -10.28 |
| 稀釋股數 | 22.4M | 22.4M | 22.4M | 22.4M | 22.4M | 22.3M | 22.3M | 22.0M | 1.3M | 1.2M | 1.2M | 1.2M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 20.2M | 17.5M | 17.9M | 15.0M | 14.7M | 15.1M | 40.2M | 31.4M | 25.1M | 23.7M | 21.0M | 41.3M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 73.7M | 141M | 157M | 169M | 179M | 191M | 175M | 188M | 117M | 130M | – | – |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 7.8M | 54.6M | 58.4M | 58.6M | 56.8M | 54.7M | – | – | – | 9.4M | – | – |
| 股東權益 | 66.0M | 86.4M | 98.7M | 110M | 123M | 137M | 165M | 179M | −141M | −127M | −116M | −104M |
| 負債比 | 10.5% | 38.7% | 37.2% | 34.7% | 31.6% | 28.6% | – | – | – | 7.2% | – | – |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −15.0M+3% | – | – | – | −14.5M | – | – | −15.8M | – | – | – |
| 資本支出 | – | 8K | – | – | – | 59K | – | – | 83K | – | – | – |
| 自由現金流 | – | −15.0M+3% | – | – | – | −14.6M | – | – | −15.9M | – | – | – |
| 折舊攤銷 | 1.3M | 284K | 334K | 300K | 300K | 317K | 300K | 300K | 263K | 357K | 200K | 200K |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | – | – | −58.2M | –% | -2.60 | −47.2M |
| FY2024 | – | – | −65.4M | –% | -3.85 | −63.4M |
| FY2023 | – | – | −49.4M | –% | -40.65 | −47.5M |